A Retrospective Study of the Impact of 21-Gene Recurrence Score Assay on Treatment Choice in Node Positive Micrometastatic Breast Cancer

To assess clinical utility of the 21-gene assay (Oncotype DX(®) Recurrence Score(®)), we determined whether women with HER2(−)/ER+ pN1mi breast cancer with low (<18) Recurrence Scores results are given adjuvant chemotherapy in a lower proportion than those with high scores (≥31). This was a multi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Frazier, Thomas G., Fox, Kevin R., Smith, J. Stanley, Laronga, Christine, McSwain, Anita, Paul, Devchand, Schultz, Michael, Stilwill, Joseph, Teal, Christine, Weisberg, Tracey, Vacchino, Judith F., Sing, Amy P., Cherepanov, Dasha, Hsiao, Wendy, Chang, Eunice, Broder, Michael S.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381203/
https://ncbi.nlm.nih.gov/pubmed/25789420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph8010107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados